Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Overdiagnosis in breast cancer chemoprevention trials.

Literature DB >> 25684995

Overdiagnosis in breast cancer chemoprevention trials.

V Sopik¹, S A Narod¹.

Abstract

Entities: Disease

Year: 2015 PMID： 25684995 PMCID： PMC4324352 DOI： 10.3747/co.22.2191

Source DB: PubMed Journal: Curr Oncol ISSN： 1198-0052 Impact factor: 3.677

× No keyword cloud information.

27 in total

1. Exemestane for breast-cancer prevention in postmenopausal women.

Authors: Paul E Goss; James N Ingle; José E Alés-Martínez; Angela M Cheung; Rowan T Chlebowski; Jean Wactawski-Wende; Anne McTiernan; John Robbins; Karen C Johnson; Lisa W Martin; Eric Winquist; Gloria E Sarto; Judy E Garber; Carol J Fabian; Pascal Pujol; Elizabeth Maunsell; Patricia Farmer; Karen A Gelmon; Dongsheng Tu; Harriet Richardson
Journal: N Engl J Med Date: 2011-06-04 Impact factor: 91.245

2. Effects of raloxifene on cardiovascular events and breast cancer in postmenopausal women.

Authors: Elizabeth Barrett-Connor; Lori Mosca; Peter Collins; Mary Jane Geiger; Deborah Grady; Marcel Kornitzer; Michelle A McNabb; Nanette K Wenger
Journal: N Engl J Med Date: 2006-07-13 Impact factor: 91.245

3. Tamoxifen for the prevention of breast cancer: current status of the National Surgical Adjuvant Breast and Bowel Project P-1 study.

Authors: Bernard Fisher; Joseph P Costantino; D Lawrence Wickerham; Reena S Cecchini; Walter M Cronin; Andre Robidoux; Therese B Bevers; Maureen T Kavanah; James N Atkins; Richard G Margolese; Carolyn D Runowicz; Joan M James; Leslie G Ford; Norman Wolmark
Journal: J Natl Cancer Inst Date: 2005-11-16 Impact factor: 13.506

4. Tumour characteristics among women with very low-risk breast cancer.

Authors: S A Narod; A Valentini; S Nofech-Mozes; P Sun; W Hanna
Journal: Breast Cancer Res Treat Date: 2012-05-01 Impact factor: 4.872

5. Palpable presentation of breast cancer persists in the era of screening mammography.

Authors: Kellie L Mathis; Tanya L Hoskin; Judy C Boughey; Brian S Crownhart; Kathy R Brandt; Celine M Vachon; Clive S Grant; Amy C Degnim
Journal: J Am Coll Surg Date: 2010-03 Impact factor: 6.113

6. Twenty-year follow-up of the Royal Marsden randomized, double-blinded tamoxifen breast cancer prevention trial.

Authors: Trevor J Powles; Sue Ashley; Alwynne Tidy; Ian E Smith; Mitch Dowsett
Journal: J Natl Cancer Inst Date: 2007-02-21 Impact factor: 13.506

7. Continuing outcomes relevant to Evista: breast cancer incidence in postmenopausal osteoporotic women in a randomized trial of raloxifene.

Authors: Silvana Martino; Jane A Cauley; Elizabeth Barrett-Connor; Trevor J Powles; John Mershon; Damon Disch; Roberta J Secrest; Steven R Cummings
Journal: J Natl Cancer Inst Date: 2004-12-01 Impact factor: 13.506

8. Tamoxifen for the prevention of breast cancer: late results of the Italian Randomized Tamoxifen Prevention Trial among women with hysterectomy.

Authors: Umberto Veronesi; Patrick Maisonneuve; Nicole Rotmensz; Bernardo Bonanni; Peter Boyle; Giuseppe Viale; Alberto Costa; Virgilio Sacchini; Roberto Travaglini; Giuseppe D'Aiuto; Pasquale Oliviero; Francesco Lovison; Giacomo Gucciardo; Marco Rosselli del Turco; Maria Grazia Muraca; Maria Antonietta Pizzichetta; Serafino Conforti; Andrea Decensi
Journal: J Natl Cancer Inst Date: 2007-05-02 Impact factor: 13.506

9. Twenty five year follow-up for breast cancer incidence and mortality of the Canadian National Breast Screening Study: randomised screening trial.

Authors: Anthony B Miller; Claus Wall; Cornelia J Baines; Ping Sun; Teresa To; Steven A Narod
Journal: BMJ Date: 2014-02-11